Ergoteles’s Mesa Laboratories MLAB Stock Holding History

Ergoteles’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-900	Closed	-$244K	–	1498
2021 Q2	$244K	Buy	+900	New	+$228K	0.01%	1177

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Ergoteles's MLAB Position: Q3 2021 in Review

Ergoteles sold out of Mesa Laboratories (MLAB) in Q3 2021, closing a stake of 900 shares — an estimated $244K sold.

Ergoteles first reported a position in MLAB in Q2 2021 and held it in 1 quarter. The position peaked at $244K in Q2 2021. 172 funds tracked by Wall St. Rank hold MLAB as of Q3 2021.

Ergoteles reported no remaining Mesa Laboratories position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 900 Mesa Laboratories shares in Q3 2021, an estimated $244K.
Ergoteles first reported a position in Mesa Laboratories in Q2 2021 and held it in 1 quarter.
Ergoteles's Mesa Laboratories position peaked at $244K in Q2 2021.
172 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.